Aptar Pharma, a leading drug delivery systems provider, announces that Nanopharm has won an Excellence in Pharma Award at the 2019 CPhI Pharma Awards. Nanopharm, an Aptar Pharma company and part of their expanded services offering, won in the Contract Services and Outsourcing category for its recently-launched SmartTrack™ process.
Accepting the award were Dr. Jag Shur, CEO of Nanopharm, and Guillaume Brouet, Vice-President of Analytical, Regulatory and Scientific Affairs at Aptar Pharma. The award was presented as part of the 16th annual CPhI Pharma Awards dinner, which took place Tuesday, November 5th at the Forum at Messe Frankfurt, Germany.
Established in 2004, the CPhI Pharma Awards are one of the most prestigious recognitions in the Pharmaceutical industry today, and celebrate the innovation and dedication of companies and individuals who are driving the pharmaceutical industry forward. This year’s awards included 13 categories that span the entire industry’s supply chain.
A specialist in respiratory drug delivery services, Nanopharm is the world’s leading contract provider of orally inhaled and nasal drug product (OINDP) design and formulation development services to customers worldwide. Recognized for their advanced scientific understanding, Nanopharm offers an integrated solution approach via SmartTrack™.
SmartTrack™ is a novel integrated solution providing an alternative bioequivalence (BE) clinical endpoint approach. SmartTrack™ can dramatically decrease program costs, mitigate risk and expedite development from concept to delivery, ensuring that every aspect of a drug product development’s critical path is optimized.
“This award marks a significant milestone for our SmartTrack™ platform, and signifies the R&D endeavor at Nanopharm to develop alternative bioequivalence strategies for OINDPs,” commented Jag Shur, PhD, Chief Executive Officer of Nanopharm. “I would like to thank our employees, clients and partners in this success.”
Aptar Pharma President Gael Touya, who was on hand to present the Excellence in Pharma Drug Delivery Device and Packaging Awards at this year’s event added, “We are delighted that Nanopharm’s SmartTrack™ was recognized by the industry for its innovative approach. This reinforces the Aptar Pharma Services mission to further help customers during their entire product lifecycle of the drug product and deliver them a complete solution.”
Aptar Pharma, along with Nanopharm, are a main exhibitor at CPhI Worldwide 2019, which is taking place in Frankfurt, Germany from November 5 – 7. For several years, Aptar Pharma has had a significant presence at this major event in the pharmaceutical industry attended by over 45,000 Pharma professionals.
About Nanopharm Nanopharm is a leading provider of tailored analytical and drug development services, with a focus on orally inhaled and nasal drug products. The company’s unique processing technologies and formulation development tools enable seamless translation of pre-clinical development through to clinical manufacturing. Nanopharm’s integrated development services in materials characterization, formulation development and inhaled biopharmaceutics aids successful product development by understanding how material properties and processing conditions influence product functionality. For more information, visit www.nanopharm.co.uk.
About Aptar Pharma
Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing, sealing and active packaging solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. Aptar uses insights, design, engineering and science to create innovative packaging technologies that build brand value for its customers, and, in turn, make a meaningful difference in the lives, looks, health and homes of people around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 14,000 dedicated employees in 18 different countries. For more information, visit www.aptar.com/pharma.